Yahoo Web Search

Search results

    • 1 Disruptive Biotech Stock to Buy Now, and 1 to Consider

      The Motley Fool via AOL· 2 days ago

      To accomplish that, it'll need to survive long enough to advance its flagship program, VK2735, through its remaining late-stage clinical trials. As the company doesn't yet have any medicines ...